These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
509 related articles for article (PubMed ID: 10586077)
1. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. Le Y; Gong W; Li B; Dunlop NM; Shen W; Su SB; Ye RD; Wang JM J Immunol; 1999 Dec; 163(12):6777-84. PubMed ID: 10586077 [TBL] [Abstract][Full Text] [Related]
2. T21/DP107, A synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors. Su SB; Gao Jl; Gong Wh; Dunlop NM; Murphy PM; Oppenheim JJ; Wang JM J Immunol; 1999 May; 162(10):5924-30. PubMed ID: 10229829 [TBL] [Abstract][Full Text] [Related]
3. Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils. Bae YS; Park JC; He R; Ye RD; Kwak JY; Suh PG; Ho Ryu S Mol Pharmacol; 2003 Sep; 64(3):721-30. PubMed ID: 12920210 [TBL] [Abstract][Full Text] [Related]
4. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1. Stenfeldt AL; Karlsson J; Wennerås C; Bylund J; Fu H; Dahlgren C Biochem Pharmacol; 2007 Oct; 74(7):1050-6. PubMed ID: 17692291 [TBL] [Abstract][Full Text] [Related]
5. Differential activation of formyl peptide receptor signaling by peptide ligands. Bae YS; Song JY; Kim Y; He R; Ye RD; Kwak JY; Suh PG; Ryu SH Mol Pharmacol; 2003 Oct; 64(4):841-7. PubMed ID: 14500740 [TBL] [Abstract][Full Text] [Related]
6. Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1. Hu JY; Le Y; Gong W; Dunlop NM; Gao JL; Murphy PM; Wang JM J Leukoc Biol; 2001 Jul; 70(1):155-61. PubMed ID: 11435499 [TBL] [Abstract][Full Text] [Related]
7. A new insight into the role of "old" chemotactic peptide receptors FPR and FPRL1: down-regulation of chemokine receptors CCR5 and CXCR4. Le Y; Shen W; Li B; Gong W; Dunlop NM; Wang JM Forum (Genova); 1999; 9(4):299-314. PubMed ID: 10611407 [TBL] [Abstract][Full Text] [Related]
8. The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2. Christophe T; Karlsson A; Dugave C; Rabiet MJ; Boulay F; Dahlgren C J Biol Chem; 2001 Jun; 276(24):21585-93. PubMed ID: 11285256 [TBL] [Abstract][Full Text] [Related]
9. Activation of the chemotactic peptide receptor FPRL1 in monocytes phosphorylates the chemokine receptor CCR5 and attenuates cell responses to selected chemokines. Shen W; Proost P; Li B; Gong W; Le Y; Sargeant R; Murphy PM; Van Damme J; Wang JM Biochem Biophys Res Commun; 2000 May; 272(1):276-83. PubMed ID: 10872839 [TBL] [Abstract][Full Text] [Related]
10. The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8. Fu H; Bylund J; Karlsson A; Pellmé S; Dahlgren C Immunology; 2004 Jun; 112(2):201-10. PubMed ID: 15147563 [TBL] [Abstract][Full Text] [Related]
11. F2L, a peptide derived from heme-binding protein, inhibits formyl peptide receptor-mediated signaling. Lee HY; Lee SY; Shin EH; Kim SD; Kim JM; Lee MS; Ryu SH; Bae YS Biochem Biophys Res Commun; 2007 Aug; 359(4):985-90. PubMed ID: 17577578 [TBL] [Abstract][Full Text] [Related]
12. Changes in the ratio between FPR and FPRL1 triggered superoxide production in human neutrophils-a tool in analysing receptor specific events. Fu H; Karlsson J; Björkman L; Stenfeldt AL; Karlsson A; Bylund J; Dahlgren C J Immunol Methods; 2008 Feb; 331(1-2):50-8. PubMed ID: 18166194 [TBL] [Abstract][Full Text] [Related]
13. Discovery of Trp-Nle-Tyr-Met as a novel agonist for human formyl peptide receptor-like 1. Wan HX; Zhou C; Zhang Y; Sun M; Wang X; Yu H; Yang X; Ye RD; Shen JK; Wang MW Biochem Pharmacol; 2007 Jul; 74(2):317-26. PubMed ID: 17517377 [TBL] [Abstract][Full Text] [Related]
14. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met is a potent chemotactic agonist for mouse formyl peptide receptor. He R; Tan L; Browning DD; Wang JM; Ye RD J Immunol; 2000 Oct; 165(8):4598-605. PubMed ID: 11035102 [TBL] [Abstract][Full Text] [Related]
15. Functional expression of formyl peptide receptor family in human NK cells. Kim SD; Kim JM; Jo SH; Lee HY; Lee SY; Shim JW; Seo SK; Yun J; Bae YS J Immunol; 2009 Nov; 183(9):5511-7. PubMed ID: 19843937 [TBL] [Abstract][Full Text] [Related]
16. Phagocyte activation by Trp-Lys-Tyr-Met-Val-Met, acting through FPRL1/LXA4R, is not affected by lipoxin A4. Christophe T; Karlsson A; Rabiet MJ; Boulay F; Dahlgren C Scand J Immunol; 2002 Nov; 56(5):470-6. PubMed ID: 12410796 [TBL] [Abstract][Full Text] [Related]
17. Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation. Yang D; Chen Q; Gertz B; He R; Phulsuksombati M; Ye RD; Oppenheim JJ J Leukoc Biol; 2002 Sep; 72(3):598-607. PubMed ID: 12223529 [TBL] [Abstract][Full Text] [Related]
18. A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from Staphylococcus aureus (FPRL1 inhibitory protein) that inhibits FPRL1 and FPR. Prat C; Haas PJ; Bestebroer J; de Haas CJ; van Strijp JA; van Kessel KP J Immunol; 2009 Nov; 183(10):6569-78. PubMed ID: 19846866 [TBL] [Abstract][Full Text] [Related]
19. A novel nonpeptide ligand for formyl peptide receptor-like 1. Nanamori M; Cheng X; Mei J; Sang H; Xuan Y; Zhou C; Wang MW; Ye RD Mol Pharmacol; 2004 Nov; 66(5):1213-22. PubMed ID: 15308762 [TBL] [Abstract][Full Text] [Related]
20. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. Su SB; Gong W; Gao JL; Shen W; Murphy PM; Oppenheim JJ; Wang JM J Exp Med; 1999 Jan; 189(2):395-402. PubMed ID: 9892621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]